Johnson & Johnson, the largest and most well-known healthcare company in the world, reported solid first quarter results and continues to be a nice buy in this expensive market environment. Here are 4 reasons Johnson & Johnson is a buy here.
Month: April 2018
Q1 Dividend Portfolio Review
With Q1 in the books it’s time to take a look back and see the events that occurred during the quarter. Also it’s a good time to take a look forward and see what is on the radar.
New Stock Screener Utility
I’m proud to announce I have launched a new stock screener for Custom Stock Alerts. There are several double handled sliders that allow you to quickly fine tune your filters you are interested in. There are currently the following filters:
- Market Cap
- Dividend Yield
- P/E ratio
- 52 week range
- Equity type (stocks, ETFs, preferred shares coming soon)
Enjoy the short demo:
More explained after the break.
